Phillips-Medisize ’s increased business to benefit Molex plant in Arkansas

Phillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark. Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader in consumable diagnostics cancer testing. The company in the past, though, has touted work it has done for Madison, Wis.–based Exact Sciences (Nasdaq: EXAS), maker of the take-home Cologuard colon cancer test. Cologuard test volume more than doubled to 571,000 tests in 2017. Get the full story on our sister site Medical Design & Outsourcing.  The post Phillips-Medisize’s increased business to benefit Molex plant in Arkansas appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Contract Manufacturing Diagnostics Exact Sciences Phillips-Medisize Source Type: news